Zagreb + Essen
Phase 3Completed 0 watching 0 views this week📈 Rising
77
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedAbout Zagreb + Essen
Zagreb + Essen is a phase 3 stage product being developed by Novartis for Rabies. The current trial status is completed. This product is registered under clinical trial identifier NCT01680016. Target conditions include Rabies.
Hype Score Breakdown
Clinical
27
Activity
18
Company
10
Novelty
9
Community
10
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01680016 | Phase 3 | Completed |
Competing Products
20 competing products in Rabies